Literature DB >> 2423062

Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity.

D R Guyer, S L Fine, M G Maguire, B S Hawkins, S L Owens, R P Murphy.   

Abstract

We determined the visual prognosis of 94 eyes in 92 patients having age-related macular degeneration, a discrete choroidal neovascular membrane directly under the center of the foveal avascular zone (subfoveal), and an initial visual acuity of 20/100 or better. Of the patients who were reexamined 24 months following their initial presentation, 77% had lost at least four lines of vision and 64% had lost at least six lines. Estimation of visual loss using a conservative assessment procedure showed four-line visual loss in 65% of the patients and six-line loss in 50%. In general, the better the visual acuity at the initial examination, the more likely the patient was to have a smaller choroidal neovascular membrane. These results suggest that it may be reasonable to consider a randomized clinical trial of laser photocoagulation for this group of patients with a relatively poor visual prognosis.

Entities:  

Mesh:

Year:  1986        PMID: 2423062     DOI: 10.1001/archopht.1986.01050170092029

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  32 in total

1.  A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  C Valmaggia; G Ries; P Ballinari
Journal:  Doc Ophthalmol       Date:  2001-11       Impact factor: 2.379

2.  Symmetry of disciform scars in bilateral age-related macular degeneration.

Authors:  M J Lavin; B Eldem; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

3.  Indirect photocoagulation of subfoveal choroidal neovascularization in age-related macular degeneration.

Authors:  L V Angioletti; P J Colquhoun; A D Kulik; E H Malpica
Journal:  Bull N Y Acad Med       Date:  1991 Jul-Aug

4.  Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.

Authors:  J N Kirkpatrick; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

5.  Low dose radiation for subfoveal choroidal neovascularization in age-related macular degeneration. A pilot study: radiotherapy for age-related macular degeneration.

Authors:  C Valmaggia; P Bischoff; G Ries; W Seelentag; H Niederberger; P Speiser
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

6.  Low-dose radiation therapy for age-related macular degeneration.

Authors:  H Pöstgens; S Bodanowitz; P Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

7.  Difference in treatment burden of neovascular age-related macular degeneration among different types of neovascularization.

Authors:  Ji Hyun Lee; Jae Hui Kim; Jong Woo Kim; Chul Gu Kim; Dong Won Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-06       Impact factor: 3.117

8.  Using electronic referral with digital imaging between primary and secondary ophthalmic services: a long term prospective analysis of regional service redesign.

Authors:  S Borooah; B Grant; A Blaikie; C Styles; S Sutherland; G Forrest; P Curry; J Legg; A Walker; R Sanders
Journal:  Eye (Lond)       Date:  2012-12-21       Impact factor: 3.775

9.  Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study.

Authors:  P T Finger; Y P Gelman; A M Berson; A Szechter
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

10.  Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?

Authors:  Dimitrios A Karagiannis; Ioannis D Ladas; Efstratios Parikakis; Ilias Georgalas; Athanasios Kotsolis; Giorgos Amariotakis; Vasileios Soumplis; Panagiotis Mitropoulos
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.